Nidanilimab (CAN04) is a fully humanized IL1RAP monoclonal antibody with a Kd value of 1.10 pM. Nidanilimab has antitumor activity, cutting off the IL1alpha and IL1beta signaling pathways and inducing the immune system to destroy tumor cells. Nidanilimab can be
CAS Number:
[2171061-85-9]
Target:
CAN04
* VAT and and shipping costs not included. Errors and price changes excepted